Wordt geladen...
Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.
BACKGROUND: Reactions are commonly associated with the chemotherapy of onchocerciasis. However unmanageable reactions are uncommon when ivermectin (Mectizan(®)) is used for the treatment of this infection, and this drug has proved to be a great improvement over previously used agents. Serious advers...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2003
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2147659/ https://ncbi.nlm.nih.gov/pubmed/14975062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2883-2-S1-S5 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|